Retrospective Analysis of the Risk Factors of Perioperative Bacterial Infection and Correlation with Clinical Prognosis in Kidney Transplant Recipients

References

• Port FK, Merion RM, Roys EC, Wolfe RA. Trends in organ donation and transplantation in the United States, 1997–2006. Am J Transpl. 2008;8(4 Pt 2):911–921. doi:10.1111/j.1600-6143.2008.02170.x
   Web of Science ®Google Scholar
• Martin-Gandul C, Mueller NJ, Pascual M, Manuel O. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transpl. 2015;15(12):3024–3040. doi:10.1111/ajt.13486
   PubMed Web of Science ®Google Scholar
• Fishman JA. Infection in organ transplantation. Am J Transpl. 2017;17(4):856–879. doi:10.1111/ajt.14208
   PubMed Web of Science ®Google Scholar
• Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation. 2002;73(12):1923–1928. doi:10.1097/00007890-200206270-00013
   Web of Science ®Google Scholar
• Kinnunen S, Karhapää P, Juutilainen A, Finne P, Helanterä I. Secular trends in infection-related mortality after kidney transplantation. Clin J Am Soc Nephrol. 2018;13(5):755–762. doi:10.2215/CJN.11511017
   Web of Science ®Google Scholar
• Dharnidharka VR, Agodoa LY, Abbott KC. Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients–an analysis of USRDS data. Am J Transpl. 2007;7(3):653–661. doi:10.1111/j.1600-6143.2006.01674.x
   Web of Science ®Google Scholar
• Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513–521. doi:10.2337/dc17-2131
   PubMed Web of Science ®Google Scholar
• Hayer MK, Farrugia D, Begaj I, Ray D, Sharif A. Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus. Diabetologia. 2014;57(3):554–561. doi:10.1007/s00125-013-3124-5
   PubMed Web of Science ®Google Scholar
• Simonsen JR, Järvinen A, Harjutsalo V, Forsblom C, Groop PH, Lehto M. The association between bacterial infections and the risk of coronary heart disease in type 1 diabetes. J Intern Med. 2020;288(6):711–724. doi:10.1111/joim.13138
   Web of Science ®Google Scholar
• Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338(6108):768–772. doi:10.1126/science.1224577
   PubMed Web of Science ®Google Scholar
• Mooney JP, Galloway LJ, Riley EM. Malaria, anemia, and invasive bacterial disease: a neutrophil problem?. J Leukoc Biol. 2019;105(4):645–655. doi:10.1002/JLB.3RI1018-400R
   PubMed Web of Science ®Google Scholar
• Helanterä I, Schachtner T, Hinrichs C, et al. Current characteristics and outcome of cytomegalovirus infections after kidney transplantation. Transpl Infect Dis. 2014;16(4):568–577. doi:10.1111/tid.12247
   Web of Science ®Google Scholar
• Jouve T, Noble J, Rostaing L, Malvezzi P. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization. Expert Opin Drug Saf. 2019;18(4):285–294. doi:10.1080/14740338.2019.1599858
   PubMed Web of Science ®Google Scholar
• Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2016 annual data report: kidney. Am J Transpl. 2018;18(Suppl1):18–113. doi:10.1111/ajt.14557
   Web of Science ®Google Scholar
• Pallardó Mateu LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol Dial Transpl. 2004;19(Suppl 3):iii38–iii42. doi:10.1093/ndt/gfh1013
   Web of Science ®Google Scholar
• Song GG, Lee YH. Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis. Int J Clin Pharmacol Ther. 2020;58(10):550–556. doi:10.5414/CP203736
   Web of Science ®Google Scholar
• Ministry of Health, PRC. Diagnostic criteria for nosocomial infection (Trial). Chin Med J. 2001;05(61–67):10–12.
   Google Scholar
• Hjelmesaeth J, Jenssen T, Hartmann A. Diagnosing PTDM. Transplantation. 2003;75(10):1761. doi:10.1097/01.TP.0000064543.07931.F6
   Web of Science ®Google Scholar
• Illesy L, Szabo-Pap M, Toth F, et al. Bacterial infections after kidney transplantation: a single-center experience. Transpl Proc. 2016;48(7):2540–2543. doi:10.1016/j.transproceed.2016.07.011
   Web of Science ®Google Scholar
• Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand MR. Infectious complications after kidney transplantation: a single-center experience. Transpl Infect Dis. 2007;9(4):302–309. doi:10.1111/j.1399-3062.2007.00229.x
   Web of Science ®Google Scholar
• Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9):e13507. doi:10.1111/ctr.13507
   PubMed Web of Science ®Google Scholar
• Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transpl. 2013;18:195–204. doi:10.12659/AOT.883901
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Agodoa LY, Abbott KC. Effects of urinary tract infection on outcomes after renal transplantation in children. Clin J Am Soc Nephrol. 2007;2(1):100–106. doi:10.2215/CJN.01820506
   Web of Science ®Google Scholar
• Greissman S, Mattiazzi A, Mendoza M, et al. Antimicrobial resistance and recurrent bacterial urinary tract infections in hospitalized patients following kidney transplantation: a single-center experience. Transpl Infect Dis. 2020;22(4):e13337. doi:10.1111/tid.13337
   Web of Science ®Google Scholar
• Bodro M, Sanclemente G, Lipperheide I, et al. Impact of urinary tract infections on short-term kidney graft outcome. Clin Microbiol Infect. 2015;21(12):1104.e1101–1108. doi:10.1016/j.cmi.2015.07.019
   Web of Science ®Google Scholar
• Soylu L, Aydin OU, Atli M, et al. Does early removal of double J stents reduce urinary infection in living donor renal transplantation?. Arch Med Sci. 2019;15(2):402–407. doi:10.5114/aoms.2018.73524
   Web of Science ®Google Scholar
• Visser IJ, van der Staaij JPT, Muthusamy A, Willicombe M, Lafranca JA, Dor F. Timing of ureteric stent removal and occurrence of urological complications after kidney transplantation: a systematic review and meta-analysis. J Clin Med. 2019;8:5. doi:10.3390/jcm8050689
   Web of Science ®Google Scholar
• Fiorentino M, Pesce F, Schena A, Simone S, Castellano G, Gesualdo L. Updates on urinary tract infections in kidney transplantation. J Nephrol. 2019;32(5):751–761. doi:10.1007/s40620-019-00585-3
   PubMed Web of Science ®Google Scholar
• Rich J, Lee JC. The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes. 2005;54(10):2904–2910. doi:10.2337/diabetes.54.10.2904
   Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487–48490. doi:10.1074/jbc.R400025200
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812. doi:10.1172/JCI200318921
   PubMed Web of Science ®Google Scholar
• Vincent JL, Russell JA, Jacob M, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231. doi:10.1186/cc13991
   PubMed Web of Science ®Google Scholar
• Artigas A, Wernerman J, Arroyo V, Vincent JL, Levy M. Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care. 2016;33:62–70. doi:10.1016/j.jcrc.2015.12.019
   PubMed Web of Science ®Google Scholar
• Minatoguchi S, Nomura A, Imaizumi T, et al. Low serum albumin as a risk factor for infection-related in-hospital death among hemodialysis patients hospitalized on suspicion of infectious disease: a Japanese multicenter retrospective cohort study. Ren Replace Ther. 2018;4(1):30. doi:10.1186/s41100-018-0173-8
   Google Scholar
• Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol. 2008;3(3):759–767. doi:10.2215/CJN.02720707
   Web of Science ®Google Scholar
• Becker BN, Becker YT, Heisey DM, et al. The impact of hypoalbuminemia in kidney-pancreas transplant recipients. Transplantation. 1999;68(1):72–75. doi:10.1097/00007890-199907150-00014
   PubMed Web of Science ®Google Scholar
• Haller C. Hypoalbuminemia in renal failure: pathogenesis and therapeutic considerations. Kidney Blood Press Res. 2005;28(5–6):307–310. doi:10.1159/000090185
   Web of Science ®Google Scholar
• Ma ZZ, Li L, Han YX, Duan YD, Wang WZ, Niu ME. Analysis of risk factors for early urinary tract infection after kidney transplantation. Transl Androl Urol. 2020;9(5):2211–2217. doi:10.21037/tau-20-1248
   Web of Science ®Google Scholar
• Mazzeffi M, Jonna S, Blanco N, et al. Intraoperative red blood cell transfusion, delayed graft function, and infection after kidney transplant: an observational cohort study. J Anesth. 2018;32(3):368–374. doi:10.1007/s00540-018-2484-x
   Web of Science ®Google Scholar
• Flabouris K, Chadban S, Ladhani M, Cervelli M, Clayton P. Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study. Nephrol Dial Transpl. 2019;34(12):2132–2143. doi:10.1093/ndt/gfz095
   Web of Science ®Google Scholar
• Shields RK, Clancy CJ, Minces LR, et al. Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes. J Heart Lung Transpl. 2012;31(11):1199–1206. doi:10.1016/j.healun.2012.08.012
   Web of Science ®Google Scholar
• BaniHani MN, Khabour OF, Alzoubi KH, et al. The association between ABCB1 C1236T/C3435T SNPs and H. pylori infection among Jordanians. Genes. 2020;11:1. doi:10.3390/genes11010063
   Web of Science ®Google Scholar
• Van Matre ET, Satyanarayana G. Pharmacokinetic drug-drug interactions between immunosuppressant and anti-infective agents: antimetabolites and corticosteroids. Ann Transpl. 2018;23:66–74. doi:10.12659/AOT.906164
   Web of Science ®Google Scholar
• Berdaguer S, Bautista J, Brunet M, Cisneros JM. Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients. Enferm Infecc Microbiol Clin. 2012;30(Suppl 2):86–92. doi:10.1016/S0213-005X(12)70087-3
   Google Scholar
• Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis. 1997;25(6):1430–1440. doi:10.1086/516138
   PubMed Web of Science ®Google Scholar
• Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients. Br J Clin Pharmacol. 2019;85(3):516–529. doi:10.1111/bcp.13811
   PubMed Web of Science ®Google Scholar
• Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transpl. 2010;10(12):2615–2623. doi:10.1111/j.1600-6143.2010.03310.x
   Web of Science ®Google Scholar
• Kim JS, Jeong KH, Lee DW, et al. Epidemiology, risk factors, and clinical impact of early post-transplant infection in older kidney transplant recipients: the Korean organ transplantation registry study. BMC Geriatr. 2020;20(1):519. doi:10.1186/s12877-020-01859-3
   Web of Science ®Google Scholar
• Møller DL, Sørensen SS, Wareham NE, et al. Bacterial and fungal bloodstream infections in pediatric liver and kidney transplant recipients. BMC Infect Dis. 2021;21(1):541. doi:10.1186/s12879-021-06224-2
   Web of Science ®Google Scholar
• Lee JR, Bang H, Dadhania D, et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96(8):732–738. doi:10.1097/TP.0b013e3182a04997
   PubMed Web of Science ®Google Scholar
• Erdbruegger U, Scheffner I, Mengel M, et al. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transpl. 2012;27(1):435–443. doi:10.1093/ndt/gfr306
   Web of Science ®Google Scholar
• Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev. 2016;37(1):37–61. doi:10.1210/er.2015-1084
   PubMed Web of Science ®Google Scholar
• Ahmed SH, Biddle K, Augustine T, Azmi S. Post-transplantation diabetes mellitus. Diabetes Ther. 2020;11(4):779–801. doi:10.1007/s13300-020-00790-5
   PubMed Web of Science ®Google Scholar